发明授权
US5668133A Ophthalmic compositions comprising emedastine and methods for their use
失效
包含依达斯汀的眼用组合物及其使用方法
- 专利标题： Ophthalmic compositions comprising emedastine and methods for their use
- 专利标题（中）： 包含依达斯汀的眼用组合物及其使用方法
-
申请号： US445850申请日： 1995-05-22
-
公开(公告)号： US5668133A公开(公告)日： 1997-09-16
- 发明人: John M. Yanni , Stella M. Robertson , Shigetoshi Okumura , Hitoshi Tanaka , Tadayuki Saito
- 申请人： John M. Yanni , Stella M. Robertson , Shigetoshi Okumura , Hitoshi Tanaka , Tadayuki Saito
- 申请人地址： TX Fort Worth
- 专利权人： Alcon Laboratories, Inc.
- 当前专利权人： Alcon Laboratories, Inc.
- 当前专利权人地址： TX Fort Worth
- 主分类号： A61K31/50
- IPC分类号： A61K31/50
摘要：
Topical ophthalmic compositions comprising 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole and its ophthalmically acceptable acid addition salts have been found to be useful in treating ocular allergies, especially allergic conjunctivitis, giant papillary conjunctivitis, and vernal conjunctivitis.
公开/授权文献
- US5100949A Overcoating agents for heat-sensitive recording materials 公开/授权日：1992-03-31
信息查询
